| Inventor | Institute |
|---|---|
| Marta Nekulová | Masaryk Memorial Cancer Institute |
| SKU: | 162296 |
|---|---|
| Product description: | MDA-MB-468 cell line expressing the TAp63? isoform of p63 protein after induction with tetracycline |
| Alternate name: | MDA-MB-468 pcDNA6/TR pT-REX-DEST30-TAp63 alpha |
| Gender: | Female |
| CRISPR: | Yes |
| Conditional: | Yes |
| Conditional description: | the TAp63? isoform of p63 protein is conditionally expressed after induction with tetracycline |
| Parental cell line: | MDA-MB-468 |
| Model description: | Conditional expression of TAp63? isoform of p63 protein after induction with tetracycline |
| Disease: | Cancer |
| Cat. #: | 162296 |
|---|---|
| Tool sub type: | 10XUAS IVS p10 |
| Cancer types: | Breast cancer |
| Organism: | Human |
| Tissue: | Pleural effusion of metastatic adenocarcinoma of the breast |
| Gender: | Female |
| Model: | Transgenic |
| Morphology: | Epithelial |
| Growth properties: | Adherent |
| Primary citation: | Nekulova et al. (2016). BMC Cancer, 10;16(1):782, PMID: 27724925 |
| Format: | Frozen |
|---|---|
| Storage conditions: | Liquid Nitrogen |
| Atmosphere: | humidified CO2 atmosphere |
| Mycoplasma free: | Yes |
| References: |
Holcakova et al. (2017). Breast Cancer Res Treat. 163(3):475-484, PMID: 28349272 Nekulova et al. (2016). BMC Cancer, 10 16(1):782, PMID: 27724925 |
|---|
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.